As links between pharmaceutical companies and telehealth providers grow, health policy experts and legislators have sounded ...

A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

In a little noticed move, the company that sells the Addyi pill for female sexual dysfunction recently won regulatory approval in Canada, thanks to a followup study designed to address a nagging ...

Sprout Pharmaceuticals' female libido drug Addyi has traveled a winding path through FDA gatekeepers, multiple M&A deals, marketing restrictions and more. With a possible new safety flag, the ...

We have recently learned that at this time, the Food and Drug Administration (FDA) has NOT revised its warnings about the use of alcohol with Addyi nor has it changed the drug’s REMS, according to an ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...

WASHINGTON --Most women with low sexual desire won't rush to get the first prescription drug to boost female libido when it becomes available on Saturday. But they may have more options down the road.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. When Kara became disinterested in sex with her husband, she knew their relationship wasn't the problem ...

Sprout Pharmaceuticals Inc. is relaunching Addyi (flibanserin), the first-ever approved drug for low libido, or hypoactive sexual desire disorder (HSDD), which affects up to six million pre-menopausal ...